Deep-Learning Model for Real-Time Prediction of Recurrence in Early-Stage Non-Small Cell Lung Cancer: A Multimodal
Hyun Ae Jung1, Daehwan Lee2, Boram Park3,4
1Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
A new deep-learning model predicts recurrence in early-stage non-small cell lung cancer (NSCLC) using routine clinical data. This RADAR score offers timely risk assessment to guide personalized surveillance and treatment strategies for NSCLC patients.
Area of Science:
- Oncology
- Artificial Intelligence
- Medical Informatics
Background:
- Current surveillance for early-stage non-small cell lung cancer (NSCLC) lacks personalization based on individual recurrence risk factors.
- Longitudinal monitoring protocols are essential for timely detection of recurrence in NSCLC survivors.
Purpose of the Study:
- To develop and validate a deep-learning model for predicting recurrence in early-stage NSCLC using comprehensive clinical data.
- To create a practical tool for longitudinal monitoring that incorporates individualized risk assessment.
Main Methods:
- A multimodal deep-learning model utilizing transformers was developed for real-time recurrence prediction.
- The model integrated baseline clinical, pathological, and molecular data with longitudinal laboratory and radiologic surveillance data.
- Data from 14,177 patients with stage I-III NSCLC treated with curative intent between 2008-2022 were analyzed.
Main Results:
- The deep-learning model incorporated 64 distinct factors and demonstrated strong predictive performance.
- The area under the curve (AUC) for predicting recurrence within one year was 0.854 across all stages.
- The model achieved a sensitivity of 86.0% and specificity of 71.3%, with stage-specific AUCs ranging from 0.724 to 0.872.
Conclusions:
- A deep-learning model using multimodal data from routine clinical practice can effectively predict relapse in early-stage NSCLC.
- The developed RADAR risk score provides timely, actionable insights for clinicians.
- This tool has the potential to guide risk-adapted surveillance and optimize adjuvant systemic treatment decisions for NSCLC patients.
More Related Videos
07:53Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
Published on: October 13, 2023
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
